$CW

Watts John C sold $166K of CW

Watts John C (EVP & Chief Growth Officer) sold 220 shares of CURTISS WRIGHT CORP (CW) at $752.91 ($0.17M total) on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Watts John C
Published May 27, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CW
Neutral
high confidence
Mentioned
$CW
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CWNeutralLow
01

Why it matters

The newest fact is the specific sale: 220 shares at $752.91 totaling $165,640.20, executed on 2026-05-27 under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation and lack of fundamental updates make it low-signal for price action.

03

What to watch

The sale size is small relative to typical institutional flows, and the filing lacks context on total holdings, other grants, or whether future scheduled sales are larger.

Relevance 3/10Novelty 3/10Timing: Filed 2026-05-27, after-hours/late session disclosure window.

Background

The article is a primary-source SEC Form 4 insider transaction for Curtiss-Wright (CW).

Company-level read

Ticker impact

$CWNeutralHigh confidence
Context

Curtiss-Wright Form 4 shows EVP and Chief Growth Officer Watts sold 220 shares at $752.91 on 2026-05-27 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move driven by this filing alone.

Evidence & confidence

The disclosure is an open-market sale by an insider, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

Minimal, as the filing does not change guidance, contracts, or regulatory posture for the industrials/aerospace supply chain.

None indicated; this is company-specific insider transaction data.

None indicated; no cross-border deal or macro linkage is described.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with internal risk management or diversification, which some traders may interpret as mild negative sentiment.

Key entities

  • Curtiss-Wright Corp

    Subject of the Form 4 insider transaction disclosure.

  • Watts John C

    EVP and Chief Growth Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CWMed

Curtiss-Wright wins over $225M in U.S. Navy contracts

Curtiss-Wright (NYSE:CW) secured over $225M in U.S. Navy contracts for submarine and aircraft carrier programs, supplying propulsion valves, pumps, and control systems. Work will be done at NY and PA facilities, continuing through 2030. The company has supported the U.S. Naval Nuclear Propulsion Program for over 60 years.